2BB score and signals
Lantern Pharma Inc.’s current 2BB score is 19 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 5 | Very Low |
| Momentum | 24 | Weakening |
| Financial strength | 6 | Very Weak |
| Quality | 40 | Normal |
| Risk | 49 | Moderate |
Company facts
| Headquarters | Dallas, Texas, United States |
| Founded | 2013 |
| Employees | 16 |
| 52-week range | $1.11 – $4.75 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-11 | — | -0.357 | — | $0.00 |
| 2026-08-14 | -0.28 | -0.3876 | $0.00 | $0.00 |
| 2026-05-15 | -0.3 | -0.3672 | $0.00 | $0.00 |
| 2026-03-30 | -0.36 | -0.4692 | $0.00 | $0.00 |
Related companies
